Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neda Kalhor

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
Ebiomedicine|November 27, 2019
ConvPath: A software tool for lung adenocarcinoma digital pathological image analysis aided by a convolutional neural networkShidan Wang, Tao Wang, Lin Yang, et al.
Oncotarget|March 28, 2018
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancerDaniel Richard Gomez, Lauren Averett Byers, Monique Nilsson, et al.
Molecular Cancer Therapeutics|July 22, 2017
JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung CancerKazuhiko Shien, Vassiliki A Papadimitrakopoulou, Dennis Ruder, et al.
The Annals of Thoracic Surgery|December 9, 2017
Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung CancerTina Cascone, Kathryn A Gold, Stephen G Swisher, et al.
Clinical Lung Cancer|April 14, 2020
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant ChemotherapyAnnikka Weissferdt, Apar Pataer, Ara A Vaporciyan, et al.
Journal of the National Cancer Institute|February 25, 2014
Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancerHumam Kadara, Junya Fujimoto, Suk-Young Yoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma PatientsEdwin R Parra, Carmen Behrens, Jaime Rodriguez-Canales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2013
Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinomaIgnacio I Wistuba, Carmen Behrens, Francesca Lombardi, et al.
Cell Reports|August 2, 2016
Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung TumorigenesisMahesh S Padanad, Georgia Konstantinidou, Niranjan Venkateswaran, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2016
Validation of SCT Methylation as a Hallmark Biomarker for Lung CancersYu-An Zhang, Xiaotu Ma, Adwait Sathe, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
Ebiomedicine|November 27, 2019
ConvPath: A software tool for lung adenocarcinoma digital pathological image analysis aided by a convolutional neural networkShidan Wang, Tao Wang, Lin Yang, et al.
Oncotarget|March 28, 2018
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancerDaniel Richard Gomez, Lauren Averett Byers, Monique Nilsson, et al.
Molecular Cancer Therapeutics|July 22, 2017
JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung CancerKazuhiko Shien, Vassiliki A Papadimitrakopoulou, Dennis Ruder, et al.
The Annals of Thoracic Surgery|December 9, 2017
Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung CancerTina Cascone, Kathryn A Gold, Stephen G Swisher, et al.
Clinical Lung Cancer|April 14, 2020
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant ChemotherapyAnnikka Weissferdt, Apar Pataer, Ara A Vaporciyan, et al.
Journal of the National Cancer Institute|February 25, 2014
Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancerHumam Kadara, Junya Fujimoto, Suk-Young Yoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma PatientsEdwin R Parra, Carmen Behrens, Jaime Rodriguez-Canales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2013
Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinomaIgnacio I Wistuba, Carmen Behrens, Francesca Lombardi, et al.
Cell Reports|August 2, 2016
Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung TumorigenesisMahesh S Padanad, Georgia Konstantinidou, Niranjan Venkateswaran, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2016
Validation of SCT Methylation as a Hallmark Biomarker for Lung CancersYu-An Zhang, Xiaotu Ma, Adwait Sathe, et al.
Pageof 14